Imphal-Ravispecialitiespharma Private Limited - Company Profile

It is a pharma private limited company based in Imphal, Manipur, India, established in 2018.
2018 Imphal, Manipur, India Active
Last Updated:
Access Report
About Imphal-Ravispecialitiespharma Private Limited

Imphal-Ravispecialitiespharma Private Limited, a active private limited company, was established on 01 February 2018 in Imphal, Manipur, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U33208MN2018PTC013626. Registered under ROC Roc Guwahati. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Thangavel Ranjith (Director), Mummachi Thangavel (Director). Past directors included Surjitkumar. It is based at Khuyathong Road, Thangal Bazar Near Post Office,, Imphal, Manipur, 795001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33208MN2018PTC013626

  • Registration Number

    013626

  • Incorporation Date

    01 February 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Guwahati

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 7 Days
Company report

Imphal-Ravispecialitiespharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Imphal-Ravispecialitiespharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Imphal-Ravispecialitiespharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Thangavel Ranjith Director 01 Feb 2018 Current
Mummachi Thangavel Director 01 Feb 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 01 Jul 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Imphal-Ravispecialitiespharma.

Enhance accessibility to Imphal-Ravispecialitiespharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Imphal-Ravispecialitiespharma revenue growth over time
Imphal-Ravispecialitiespharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Imphal-Ravispecialitiespharma?

Unlock access to Imphal-Ravispecialitiespharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Imphal-Ravispecialitiespharma?

Unlock and access historical data on people associated with Imphal-Ravispecialitiespharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Imphal-Ravispecialitiespharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imphal-Ravispecialitiespharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Imphal-Ravispecialitiespharma
Recent Activity within the Organization
  • Director Appointment

    Thangavel Ranjith was appointed as a Director was appointed as a Director on 01 Feb 2018 & has been associated with this company since 8 years 7 days . was recorded as a recent event.

  • Director Appointment

    Progress on Mummachi Thangavel was appointed as a Director was appointed as a Director on 01 Feb 2018 & has been associated with this company since 8 years 7 days . was documented.

  • Company Incorporation

    The activity Imphal-Ravispecialitiespharma Private Limited was registered on 01 Feb 2018 with Roc Guwahati & aged 8 years 7 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Imphal-Ravispecialitiespharma Private Limited?

The CIN of Imphal-Ravispecialitiespharma Private Limited is U33208MN2018PTC013626.

Where is Imphal-Ravispecialitiespharma Private Limited headquartered?

Imphal-Ravispecialitiespharma Private Limited is headquartered at Khuyathong Road, Thangal Bazar Near Post Office,, Imphal, Manipur, 795001.

When was Imphal-Ravispecialitiespharma Private Limited incorporated?

Imphal-Ravispecialitiespharma Private Limited was incorporated on 01 February 2018.

Who are the current directors of Imphal-Ravispecialitiespharma Private Limited?

The current directors of Imphal-Ravispecialitiespharma Private Limited are

What is the primary industry of Imphal-Ravispecialitiespharma Private Limited?

The primary industry of Imphal-Ravispecialitiespharma Private Limited is Pharma.

Is Imphal-Ravispecialitiespharma Private Limited a listed company?

Imphal-Ravispecialitiespharma Private Limited is unlisted.

What is the capital structure of Imphal-Ravispecialitiespharma Private Limited?

The authorized capital of Imphal-Ravispecialitiespharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available